Effects of Losartan-based therapy on the incidence of end-stage renal disease and associated costs in type 2 diabetes mellitus: A retrospective cost-effectiveness analysis in the United Kingdom-Reference-Cited by-同舟云学术

Effects of Losartan-based therapy on the incidence of end-stage renal disease and associated costs in type 2 diabetes mellitus: A retrospective cost-effectiveness analysis in the United Kingdom

Published:2005-11 Issue:6 Volume:66 Page:475-485
ISSN:0011-393X
Container-title:Current Therapeutic Research
language:en
Short-container-title:Current Therapeutic Research

Author:

Vora Jiten,Carides George,Robinson Paul

Publisher

Elsevier BV

Subject

Pharmacology (medical),Pharmacology

Reference21 articles.

1. Fact sheet: The cost-effectiveness of transplantation;UK Transplant,2003

2. Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy;Brenner;N Engl J Med.,2001

3. The losartan renal protection study—rationale, study design and baseline characteristics of RENAAL (Reduction of Endpoints in NIDDM with the Angiotensin II Antagonist Losartan);Brenner;J Renin Angiotensin Aldosterone Syst,2000

4. Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes;Lewis;N Engl J Med.,2001

5. Economic implications of the RENAAL study in the United Kingdom;Vora;Diabet Med.,2003

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical observation of the reduced glutathione in the treatment of diabetic chronic kidney disease;Journal of Cellular Biochemistry;2018-12-16

2. Economic evaluations of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers in type 2 diabetic nephropathy: a systematic review;BMC Nephrology;2014-01-15

3. Economic evaluation of irbesartan in combination with hydrochlorothiazide in the treatment of hypertension in Greece;The European Journal of Health Economics;2010-04-22

4. The economic benefits of preventing end-stage renal disease in patients with type 2 diabetes mellitus;Nephrology Dialysis Transplantation;2009-07-15